2023-2024 Cardiac Transthyretin Amyloid (ATTR) Fellowships 

Note: applications for 2023-2024 fellowships are now closed.

The International Society of Amyloidosis has collaborated with Pfizer on the 2023-2024 Cardiac Transthyretin Amyloid (ATTR) Fellowship Program. Applications are now closed, except for the Chicago-based fellowship described above.

The goals of the program are to:

  • Train physicians to recognize and diagnose cardiac ATTR amyloidosis
  • Foster research in the field of amyloidosis.

The main focus of the 2023-2024 fellowships will be on clinical experience rather than research.

Please read the information below carefully before completing your application.


Fellowship applicants are required to hold an MD degree or equivalent, and either be enrolled in a cardiology fellowship or have completed a cardiology fellowship. The following is also required to complete the application:

  • a letter of support from applicant's current home institution, signed by the Director or Department Chair
  • details on medical education, training and work experience
  • a statement on how the knowledge gained from a Cardiac Amyloidosis Fellowship would be used in applicant's home institution/region
  • licensure information
  • updated CV.

Finalists may be asked to provide letters of recommendation and participate in an informal Zoom interview in March of 2023.

Responsibilities of Host Institutions and Fellows

Host institutions will pay the fellow's salary via their ISA/Pfizer grants, as well as plan fellowships, assign mentors, provide onboarding and orientation, and arrange the fellow’s schedule. Host institutions will also provide guidance on housing options, and may  provide health insurance for the fellow. ISA will pay for travel expenses to and from the host institution (one round trip) up to US $2000. 

Fellows will be responsible for the following during their fellowship period:

  • Housing, food and health insurance (if insurance is not provided by hosting center)
  • Visa and immigration arrangements (ISA will make every effort to match fellows with institutions in a way that will minimize immigration issues and will provide information on any assistance hosting centers can provide)
  • Meeting all requirements of the hosting center and host country, including those related to immunizations, insurance and background checks, and signing any agreements
  • Completing ISA surveys at 6 months and 12 months, including evaluation of the program.

Selection and Matching Process

Host institution proposals from leading centers in Australia, the US, Latin America, Europe and Asia (specifically Japan) are currently being vetted by ISA's Fellowship Working Group and Board of Directors in collaboration with Pfizer. A list of hosting institution finalists will be available on this page approximately one week before fellowship applications are due. 

ISA will review fellowship applications, choose fellows and match those fellows with host institutions. Applicants will be evaluated using the following criteria:

  • Need of home institution/region for cardiac amyloidosis diagnostic and treatment knowledge
  • Ability to put knowledge into practice
  • Medical training and experience
  • Professional accomplishments.

If any top applicant is a poor match for the 2023-2024 host institutions (e.g., due to language skills or visa issues), ISA will consider the next top-ranked applicant. This means that some highly-qualified applicants may not be chosen for the 2023-2024 program. We encourage those who are not chosen to consider applying for future fellowships.


February 15, 2023 - information session (see details below)
February 16, 2023 - information session (see details below)
February 21, 2023 - list of fellowship hosting centers available
February 27, 2023 - fellowship applications due
March/April 2023 - applicants notified of status of their applications
July 1, 2023 - fellowships begin*
June 30, 2024 - fellowships end.*

*Cardiac Amyloidosis Fellowships will start on or near July 1, 2023 and end on or near June 31, 2024, unless otherwise determined by the host institution.

Go to fellowship application